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AbstrACt
Introduction Cancer is often considered a chronic 
disease, and most people with cancer have a caregiver, 
often a family member or friend who provides a significant 
amount of care during the illness trajectory. Caregivers are 
frequently in need of support, and a range of interventions 
have been trialled to improve outcomes. Consensus for 
optimal ways to support caregivers is not known. The 
aim of this protocol paper is to describe procedures for a 
modified Delphi study to explore expert consensus about 
important factors when developing caregiver interventions.
Methods and analysis Online modified Delphi 
methodology will be used to establish consensus for 
important caregiver intervention factors incorporating 
the Patient problem, Intervention, Comparison and 
Outcome framework. Round 1 will comprise a free-text 
questionnaire and invite the panel to contribute factors 
they deem important in the development and evaluation 
of caregiver interventions. Round 2 is designed to 
determine preliminary consensus of the importance of 
factors generated in round 1. The panel will be asked to 
rate each factor using a 4-point Likert-type scale. The 
option for panellists to state reasoning for their rating will 
be provided. Descriptive statistics (median scores and 
IQR) will be calculated to determine each item’s relative 
importance. Levels of consensus will be assessed based 
on a predefined consensus rating matrix. In round 3, 
factors will be recirculated including aggregate group 
responses (statistics and comment summaries) and 
panellists’ own round 2 scores. Panellists will be invited 
to reconsider their judgements and resubmit ratings using 
the same rating system as in round 2. This will result in 
priority lists based on the panel’s total rating scores.
Ethics and dissemination Ethics for this study has been 
gained from the Deakin University Human Ethics Advisory 
Group. It is anticipated that the results will be published 
in peer-reviewed journals and presented in a variety of 
forums.
IntroduCtIon 
The growing rate of people affected by 
cancer and advances in screening, early 
detection and treatment mean that more 
people are expected to live longer with the 
disease.1 Many people with cancer have a 
caregiver, often a friend or family member, 
who undertakes complex and demanding 
caregiving tasks,2 often without training or 
resources.3 Caregiver needs have shown to 
parallel or even exceed those of the person 
with cancer themselves.4 5 Negative impacts 
on caregivers have been reported and can 
include burden of care provision, depres-
sion, anxiety, reduced quality of life, loss of 
self-identity, loneliness, isolation and a need 
for more information,6–11 although some 
people also experience positives associated 
with care provision.7 12 Two-thirds of care-
givers, in a study of 200 caregivers of people 
with advanced cancer, reported providing 
over 80% of the care.2 Reported caregiving 
tasks included providing emotional support, 
administering medications, assisting with 
strengths and limitations of this study
 ► We adopted the Patient problem, Intervention, 
Comparison and Outcome framework for the retriev-
al of relevant information with which to address the 
research question and design appropriate research 
methodology to explore levels of consensus and as-
sess expert opinion.
 ► Our Delphi study methodology represents a rigor-
ous synthesis of expert opinion, can be replicated 
by other intervention researchers seeking to investi-
gate and design appropriate interventions for varied 
clinical populations.
 ► A research advisory committee is assembled to in-
form and guide the purposive sampling of relevant 
stakeholders with high expertise in relevant fields, 
which ensures the input of high-quality information.
 ► Given the paucity of evidence with regard to cancer 
healthcare professionals’ appreciation of the needs 
of caregivers, this study focuses solely on partici-
pants in professional and academic roles; however, 
data from this study will be used to inform future 
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bathing, toileting and feeding and other daily living and 
domestic tasks.2 
Several systematic reviews have been conducted 
summarising the cancer caregiver intervention litera-
ture.13–20 Northouse et al21 presented a meta-analysis of 
the efficacy of caregiver intervention trials, categorising 
interventions as psychoeducational, skills training and 
therapeutic counselling. It was concluded that inter-
ventions had small to medium effects and were able to 
reduce burden, improve coping, self-efficacy and quality 
of life.21 In a recent update of the Northouse review, 
Ferrell and Wittenberg20 identified an increase in trials, 
noting that more interventions are being conducted in 
home settings or by telephone. They also found signif-
icant diversity in intervention studies for type, dose, 
format and content of interventions as well as measures 
and reported outcomes. Furthermore, the need to trans-
late trials into practice was highlighted.20 These reviews 
outline substantial variety in how caregiver interventions 
are delivered.
Given that interventions are costly, time consuming and 
challenging to conduct, it is essential that we understand 
those likely to benefit from intervention, what needs to 
target within an intervention and when best to intervene. 
A recent international Delphi survey set out to iden-
tify priority topic areas for cancer caregiver research.22 
Topics achieving high consensus across expert panels 
included the financial impact of caregiving, routine 
screening of caregiver-reported outcomes and educating 
clinicians about caregiver needs. This research presents 
an important list of broad priorities, however there is 
opportunity to build on this work through understanding 
consensus about how caregiver interventions can be 
delivered.
The growing number of caregivers and associated 
burden requires careful consideration of multistake-
holder views in order to build a comprehensive under-
standing of the factors that matter most for developing 
appropriate support interventions. The present study 
consists of multistakeholder enquiry by using a sample 
of clinical and content experts to determine relevant 
factors for the practical and clinical delivery of caregiver 
intervention.
Aim
The aim is to solicit knowledge and consensus from rele-
vant cancer-specific healthcare and academic experts in 
order to develop guidelines for effective caregiver inter-
vention design and evaluation. The study will aim to elicit 
levels of expert consensus for five factors: (1) views on 
the caregivers who should be the target of interventions; 
(2) the content and mode of delivery of the interven-
tions; (3) the potential outcomes and benefits; (4) the 
appropriate approaches and methodologies to evaluate 




Determining critical factors for the design and evalua-
tion of caregiver interventions requires rigorous enquiry 
into available evidence and relevant expert knowledge. 
To this end, a new Delphi methodology was developed, 
which incorporates the Patient problem, Intervention, 
Comparison and Outcome (PICO) framework.23 PICO 
is a framework used to answer a well-focused clinical 
question by adopting an effective and evidence-based 
research approach.23 The PICO framework is used in 
this Delphi study to focus expert participation on system-
atically formulating factors that are directly relevant to 
addressing the question at hand. Delphi research uses a 
multistage, structured and iterative feedback process to 
elicit levels of opinion consensus on a given topic. The 
present study uses the PICO framework in combination 
with Delphi methodology to systematically generate 
new and translatable knowledge. Applying this method, 
items under each subject heading will be generated and 
prioritised based on expert consensus and guidelines for 
future caregiver intervention development formulated. 
The study flow is illustrated in figure 1. The study design 
follows the Standard Protocol Items: Recommendations 
for Interventional Trials 2013 Checklist.24
Advisory committee
As recommended for priority setting research, an advi-
sory committee has been established25 26 with topic and 
methodological experts, researchers and healthcare 
practitioners from a range of disciplines. The advisory 
committee will contribute to the selection of a sample 
of experts to be invited to the Delphi expert panel and 
develop guidelines based on the items that have achieved 
consensus.
rounds and timeline
In research areas where little is known, it is recommended 
to plan up to four Delphi rounds to ensure rigour in 
the development of items and consensus building.27 
However, where research builds on existing knowledge, 
a trend is evident towards adopting fewer rounds with 
successful outcomes. Delphi designs with fewer than four 
rounds have elicited expert agreement on topics such 
as the supportive care needs of adult cancer survivors,28 
the needs of adolescents and young adult survivors29 
and standardised criteria for automatic referral to palli-
ative care services.30 The present study requires collec-
tion of focused expert knowledge to generate pertinent 
items and understanding of expert consensus in regard 
to the importance of items in order to set priorities. A 
three-round Delphi is proposed to generate pertinent 
items (round 1), explore preliminary consensus (round 
2) and finally rate the short-listed items to determine 
priorities based on levels of consensus achieved (round 
3). The feedback process will be conducted online in 
4-week intervals31 accounting for sufficient time to gather 
input, aggregate and recirculate group responses, and to 
P
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stepwise build questionnaires as data are collected and 
analysed.
Questionnaires
Delphi is an iterative research methodology that builds 
on ongoing data collection. Its primary research proce-
dure is the systematic sequencing of questionnaires. 
Questionnaire 1 (Q1) will be available for distribution 
at the start of recruitment and questionnaire 2 (Q2) and 
questionnaire 3 (Q3) will be built based on participants’ 
input. Q1, sections A–F are outlined in the ‘Data collec-
tion and analysis’ section. Q1 (item generation) will take 
approximately 15 minutes to complete and Q2 and Q3 




Expertise is defined as having both knowledge and expe-
rience in a given field and an expert is a person with 
the capacity to articulate informed opinion and provide 
relevant input about their area of expertise.32 This study 
will purposely sample national and international experts 
in professional and academic roles from relevant back-
grounds able to provide salient information about care-
giver intervention priorities. The advisory committee 
will use its own professional networks and seek further 
referrals for eligible study participants (snowballing). 
The following list of inclusion criteria was developed to 
ensure recruitment of experts with strong understanding 
of cancer caregiver issues: (1) healthcare or allied health 
practitioner with extensive clinical practice experience in 
oncology; (2) have published in the area of cancer care-
giver research in the last 10 years; (3) sufficient written 
English skills to communicate ideas effectively and 
capable of contributing relevant input; and (4) willing-
ness and availability to complete all three rounds.
Patient and public involvement
In this study, experts are referred to as professionals 
and academics with expertise in intervention design 
and delivery, rather than caregivers or others involved 
in administration or management of support resources 
in the oncology setting. Previous Delphi studies include 
consumers as experts,29 whereas others do not include 
the target group.28 It was expected that caregivers would 
have unique views and perspectives22 that would benefit 
from being fully explored with a separate, dedicated and 
purposefully designed study, incorporating a diverse and 
representative range of caregivers. This is considered an 
important avenue for future work. Patients, their care-
givers and public are not involved in this Delphi study.
sample size
Delphi panel membership is determined by the study 
purpose and its constraints33 and can range from single 
digits to low hundreds.34 A panel of 10–18 experts is recom-
mended to ensure sufficient contributions.27 34 However, 
quality of data and levels of expert census are consid-
ered of greater importance than the statistical power of 
response,35 36 which distinguishes Delphi research from 
a quantitative survey.34 Taking account of the commonly 
high drop-out rate in Delphi studies, the recruitment 
target for this study is a maximum of 30 experts to allow 
for the input of a diversity of views while accounting for 
expected attrition. A maximum of 100 experts will be 
invited to achieve the minimum target.
recruitment
Recruitment will use email invitations containing a 
short description of the study purpose and participation 
requirements and access to Q1. Completion of Q1 will 
be considered implied consent. Participation is volun-
tary and can be withdrawn at any stage. Participants 
can request their demographic information and where 
possible other contributions to be withdrawn; however, 
due to the study’s iterative process not all contributions 
can be withdrawn once included in previous rounds. If 
Figure 1 Design of modified Delphi using a series of three 
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provided, reasons for declining or later withdrawal from 
the study will be recorded.
dAtA CollECtIon And AnAlysIs
The data collection and analysis sequence is illustrated 
in figure 2 and the procedures for each round (question-
naire) are detailed below.
Q1 generation of items
Q1 aims to elicit relevant issues for consideration (items), 
before quantitatively rating their levels of importance in 
future rounds as judged by the expert panel.
Sections A–E introduce five different factors, and these 
sections will invite experts to list at least six items they 
deem of critical importance to the subject headings intro-
duced. Additional space is provided for detailed descrip-
tions should participants wish to elaborate on their 
responses. Section F invites panellists to provide any addi-
tional comments they wish to submit. 
A. Caregiver characteristics
Are there specific groups of cancer caregivers that should 
be prioritised for intervention research? Consider rele-
vant demographic, medical, personal or clinical factors, 
to identify high priority groups.
B. Intervention components
What intervention components are important in cancer 
caregiver intervention research? Consider intervention 
content, delivery method, and setting and doses for 
delivery of optimal interventions
C. Outcomes
Cancer caregiver interventions can target various 
outcomes, including caregiver, patient or health service 
factors. Consider important outcomes for cancer care-
giver intervention, including who may benefit from inter-
ventions and for which outcomes.
D. Study characteristics
Cancer caregiver intervention outcomes can be inves-
tigated using a variety of approaches. Consider which 
methodologies are important in understanding and eval-
uating the benefits of caregiver interventions.
E. Barriers
What are the most significant barriers to the conduct of 
caregiver intervention research?
F.  Do you have any further comments about priorities for cancer 
caregiver interventions?
Q1 analysis
All data (items and explanations) will be entered and 
managed in qualitative data analysis software NVivo.37 
The analysis will involve removing identical responses 
before subjecting the list of items to interpretive content 
analysis as is consistent with the exploratory aim of the 
first questionnaire. Each item will be examined and a 
broad summarising label (code) will be assigned. These 
codes will arise from the data itself rather than be pre-de-
fined. As the analysis progresses and multiple similar and 
connected codes arise, the analyst will begin grouping 
them into summarising categories. Once all items are 
coded and sorted into categories, the analyst will re-read 
all data and refine the terminology to ensure all contri-
butions are captured. An inter-rater process will assist 
interpretative congruity as recommended for qualitative 
analysis.38 In this step, a second member of the project 
team will read all raw data and analytic work and any 
disagreement about interpretation or category develop-
ment will be discussed with the analyst until agreement is 
reached. This generates a list of statements pertaining to 
each category.
Q2 rating items
Q2 will list all generated items according to subject 
headings they were submitted under and panellists 
will be asked to rate each item’s importance in order 
to establish preliminary levels of consensus. Each 
item will be presented with a corresponding 4-point 
Likert-type scale (1=very unimportant, 2=unimportant, 
3=important, 4=very important) and an option to indi-
cate ‘no judgement’ will be provided including space 
for panellists to state their reasoning. To minimise 
Figure 2 Delphi data collection and analysis sequence.
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response bias, Q2 will list the items generated in Q1 
without response statistics (number of experts who 
contributed to each item).
Q2 analysis
Statistical analyses will be performed using IBM SPSS 
Statistics.39 Descriptive statistics (median scores and IQR) 
will be calculated to indicate each item’s relative impor-
tance based on the full response sample. Delphi studies 
use variable definitions and thresholds for determining 
opinion consensus.27 For purposes of assessing levels of 
consensus, this study will use a predefined rating matrix, 
adapted from Meskell et al,40 which is illustrated in table 1.
Q3 prioritising items
Q3 will be designed to provide panellists the opportunity 
to reconsider their responses in light of preliminary levels 
of consensus achieved about the importance of each item. 
Additionally, the panel will be presented with summary 
comments about the reasoning for judgements made by 
other panellists. To assist clarity and consistency, Q3 will 
follow the same layout as the previous one. All items will 
be relisted under their respective subject headings with 
corresponding 4-point Likert-type rating scales. Addi-
tionally, this questionnaire will include aggregated statis-
tical group responses generated for each item including: 
the level of importance of each factor based on group 
consensus thus far, a summary of group comments and 
reasoning for ratings of each item, and individual panel-
list’s own Q2 response.
Q3 analysis
Analysis for data collected in Q3 will use the same strategy 
as in the preceding round. The study aims to explore 
and quantify levels of agreement rather than achieve 
consensus, therefore this Delphi has been designed to 
progress through a predefined number of three rounds 
rather than continue until consensus is reached. Statistics 
will be calculated (median scores and IQR) to describe 
each item’s importance and group consensus will be 
determined based on the consensus rating matrix. A final 
priority list of items will be generated.
EthICs
All consented participants will be assigned a unique 
identification code. Collected demographic information 
and contact details will include: name, contact phone 
number, email address, description of professional role, 
years served in field of expertise, country of professional 
residence/affiliation. Participants’ identifiable informa-
tion will be matched with their unique identification code 
in one digital masterfile only. All data collected will be 
stored safely and securely in locked filing cabinets and in 
password protected folders on a secure drive (electronic 
data) that can be accessed only by the study investigators. 
Data will be kept for 5 years as per local ethics guidelines.
dIsCussIon
Combining the PICo framework and delphi methodology
It is recommended that evidence-based medicine include 
a rigorous process for the formulation of clinical questions 
to find precise answers.41 42 Research shows that clinicians 
cross numerous questions in their practice and that up to 
two-thirds remain unanswered.43 44 It is held that better 
question formulation and search processes can lead to 
better solving unanswered questions.42 45 To this end, 
the PICO framework was developed to facilitate focused 
formulation of answerable clinical queries.23 PICO is 
designed to elicit and precisely articulate the elements 
contained in clinicians’ queries, which is considered key 
to efficiently retrieving relevant evidence for making 
evidence-based clinical decisions46 47 and for guiding 
searches and content for systematic literature reviews.48 49 
The PICO framework lends itself to addressing questions 
such as caregiver intervention priorities, which require 
collection of items relating to caregivers themselves (P), 
the types and content of effective interventions (I) and 
the expected outcomes (O). While the study’s informa-
tion needs does not include a Comparison/Control (C) 
component, we are additionally interested in discerning 
the appropriate methodologies for evaluating and 
researching intervention outcomes. Huang  et al during 
their investigation of the PICO’s suitability for clinical 
queries found that not all questions necessarily use all 









Very unimportant One 70% or more in 
category one
60% or more in 
category one
50% or more in 
category one
Low importance
Unimportant Two 70% or more in 
category two
60% or more in 
category two
50% or more in 
category two
Important Three 70% or more in 
category three
60% or more in 
category three
50% or more in 
category three
High importance
Very important Four 70% or more in 
category four
60% or more in 
category four
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PICO components42; in their study of 59 real-world clin-
ical questions only two contained all four PICO elements. 
While the findings affirm the usefulness of PICO overall, 
it was noted that complex, real-world questions not always 
fit its formula squarely and may require modifications.42 
Our research question is focused on the need for health-
care response to the detected lack of appropriate care-
giver support.
The present study aims to collect high-quality evidence 
and expert knowledge and prioritise areas of interven-
tion and elicit levels of consensus among experts. The 
findings will be placed into context with current research 
priorities and a growing body of work aiming to improve 
cancer caregiver outcomes.22 The Delphi method is well 
suited to solicit knowledge from varied expertise and 
delineate degrees of (dis)agreement34 50 and alignment 
with other work. Delphi studies are particularly effec-
tive in investigating areas where little prior knowledge 
exists,51 where empirical data are lacking52 and, where 
priority setting is desired.34 The specific advantages of 
the Delphi method adopted in our research include: 
the ability to collect expert opinion from diverse disci-
plines,27 rapid communication processes,53 overcoming 
peer-pressure and power struggles through providing an 
anonymous forum54 and the ability to coordinate multi-
disciplinary participants across countries.33 The present 
paper aims to illustrate our study design clearly in order 
for other intervention researchers to replicate the 
approach for answering similar questions for different 
clinical populations or healthcare contexts. The combi-
nation of PICO and Delphi methodology presents a 
novel and promising approach to rigorously and rapidly 
generating instructive answers to complex healthcare 
problems.
What is an ‘expert’
The success of a Delphi study is contingent on participants 
who are able to provide relevant input on the research 
topic. The absence of specific guidelines for identifying 
experts challenge Delphi researchers to seek suitable 
participants with appropriate expertise.34 55 ‘Informed 
advocates’34 and ‘specialist in their field’33 are terms used 
by Delphi researchers, but there is little instruction about 
the specific qualities needed. In the absence of clear 
guidelines, the current study will follow the definition 
adopted by Blaschke et al,32 which describes the prerequi-
site qualities of merited Delphi panellists, ‘individuals who 
possess both knowledge and experience representative of 
the capacity to articulate informed opinion and provide 
relevant input about a given topic’ (p. 2–4). Consumers 
are not included in this research with the aim to conduct 
further work dedicated to exploring their views. Addition-
ally, exploring the views of administrators in future work 
would also generate important data.
the delphi expert panel
Depending on the research objectives, Delphi panels may 
comprise experts from a single discipline or represent a 
broad mix. A heterogeneous pool of experts may serve 
innovation and creative, combinatorial insights into 
unexplored questions through cross-pollination of exper-
tise. When a research question is already well-focused, 
a homogeneous panel of experts may serve addressing 
an identified research need. The present study requires 
focus on the singular task of determining priority items 
for developing future caregiver support intervention. It is 
necessary to engage those who contribute to healthcare 
decision-making, policy development and provision.
Issues of anonymity in delphi research
Providing participant anonymity distinguishes online 
Delphi studies from other research methodologies 
that involve expert participation, such as focus groups. 
Ensuring experts’ anonymity can mitigate the potentially 
negative impacts relating to different power relation-
ships and expert status.34 Furthermore, individuals may 
feel more confident to submit their views openly and 
freely without group pressure or judgement.33 There 
is no agreement on level of anonymity or de-identifi-
cation.34 Advantages of not providing anonymity are 
noted to promote recruitment due to association with 
other experts and introducing greater accountability for 
considered responses.34 While balancing advantages and 
disadvantages and also recognising challenges relating 
to a small but well-established cancer caregiver research 
community, the present study will preserve participant 
anonymity.
study stAtus And dIssEMInAtIon
Round 1 data collection for this study began in August 
2018. Data analysis is planned to be completed by October 
2018 and will be used to inform rounds 2 and 3, which 
are anticipated to be completed by March 2019. The final 
result of this Delphi study is planned to be submitted for 
publication by July 2019. At this stage, a lay summary of 
results will be sent to participants on completion of the 
study. Results will be presented as the total number of 
factors generated in Q1, a summary of factors taken into 
Q2 and the final results from Q3. Expert recommenda-
tions will be drafted for refinement and verification in 
ongoing research. It is anticipated that the results of this 
research project will be published in peer-reviewed jour-
nals and presented in a variety of organisational, confer-
ence and social media forums.
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